Astellas, FibroGen get extended Roxadustat approval in Japan for anemia of CKD

Astellas, FibroGen get extended Roxadustat approval in Japan for anemia of CKD

Roxadustat approval – Astellas Pharma and FibroGen have secured approval for EVRENZO (roxadustat) in Japan for the treatment of anemia associated with chronic kidney disease (CKD) in adults, who are not on dialysis. The approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) is the second in the country for roxadustat through the […]